{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T11:58:19Z","timestamp":1791979099116,"version":"4.4.0"},"reference-count":30,"publisher":"American Diabetes Association","issue":"1","license":[{"start":{"date-parts":[[2020,12,21]],"date-time":"2020-12-21T00:00:00Z","timestamp":1608508800000},"content-version":"vor","delay-in-days":39,"URL":"https:\/\/www.diabetesjournals.org\/content\/license"}],"funder":[{"DOI":"10.13039\/501100000361","name":"Diabetes UK","doi-asserted-by":"publisher","award":["16\/0005407"],"award-info":[{"award-number":["16\/0005407"]}],"id":[{"id":"10.13039\/501100000361","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","award":["NIHR4-SNMRL058"],"award-info":[{"award-number":["NIHR4-SNMRL058"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","award":["19\/005971"],"award-info":[{"award-number":["19\/005971"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["105636\/Z\/14\/Z"],"award-info":[{"award-number":["105636\/Z\/14\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["098395\/Z\/12\/Z"],"award-info":[{"award-number":["098395\/Z\/12\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01-DK-104942"],"award-info":[{"award-number":["R01-DK-104942"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["P30-DK-020595"],"award-info":[{"award-number":["P30-DK-020595"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,1,1]]},"abstract":"<jats:sec>\n                  <jats:title>OBJECTIVE<\/jats:title>\n                  <jats:p>ABCC8 mutations cause neonatal diabetes mellitus that can be transient (TNDM) or, less commonly, permanent (PNDM); \u223c90% of individuals can be treated with oral sulfonylureas instead of insulin. Previous studies suggested that people with ABCC8-PNDM require lower sulfonylurea doses and have milder neurological features than those with KCNJ11-PNDM. However, these studies were short-term and included combinations of ABCC8-PNDM and ABCC8-TNDM. We aimed to assess the long-term glycemic and neurological outcomes in sulfonylurea-treated ABCC8-PNDM.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESEARCH DESIGN AND METHODS<\/jats:title>\n                  <jats:p>We studied all 24 individuals with ABCC8-PNDM diagnosed in the U.K., Italy, France, and U.S. known to transfer from insulin to sulfonylureas before May 2010. Data on glycemic control, sulfonylurea dose, adverse effects including hypoglycemia, and neurological features were analyzed using nonparametric statistical methods.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>Long-term data were obtained for 21 of 24 individuals (median follow-up 10.0 [range 4.1\u201313.2] years). Eighteen of 21 remained on sulfonylureas without insulin at the most recent follow-up. Glycemic control improved on sulfonylureas (presulfonylurea vs. 1-year posttransfer HbA1c 7.2% vs. 5.7%, P = 0.0004) and remained excellent long-term (1-year vs. 10-year HbA1c 5.7% vs. 6.5%, P = 0.04), n = 16. Relatively high doses were used (1-year vs. 10-year dose 0.37 vs. 0.25 mg\/kg\/day glyburide, P = 0.50) without any severe hypoglycemia. Neurological features were reported in 13 of 21 individuals; these improved following sulfonylurea transfer in 7 of 13. The most common features were learning difficulties (52%), developmental delay (48%), and attention deficit hyperactivity disorder (38%).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>Sulfonylurea treatment of ABCC8-PNDM results in excellent long-term glycemic control. Overt neurological features frequently occur and may improve with sulfonylureas, supporting early, rapid genetic testing to guide appropriate treatment and neurodevelopmental assessment.<\/jats:p>\n               <\/jats:sec>","DOI":"10.2337\/dc20-1520","type":"journal-article","created":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T20:10:20Z","timestamp":1605211820000},"page":"35-42","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":54,"title":["Long-term Follow-up of Glycemic and Neurological Outcomes in an International Series of Patients With Sulfonylurea-Treated <i>ABCC8<\/i> Permanent Neonatal Diabetes"],"prefix":"10.2337","volume":"44","clinical-trial-number":[{"clinical-trial-number":"nct02624830","registry":"10.18810\/clinical-trials-gov","type":"results"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5241-7700","authenticated-orcid":false,"given":"Pamela","family":"Bowman","sequence":"first","affiliation":[{"name":"Exeter NIHR Clinical Research Facility, Royal Devon and Exeter NHS Foundation Trust, Exeter, U.K."},{"name":"Institute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances","family":"Mathews","sequence":"additional","affiliation":[{"name":"Exeter NIHR Clinical Research Facility, Royal Devon and Exeter NHS Foundation Trust, Exeter, U.K."},{"name":"Institute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4687-980X","authenticated-orcid":false,"given":"Fabrizio","family":"Barbetti","sequence":"additional","affiliation":[{"name":"Department of Experimental Medicine, University of Rome Tor Vergata, Rome, Italy"},{"name":"Bambino Ges\u00f9 Children\u2019s Hospital, IRCCS, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maggie H.","family":"Shepherd","sequence":"additional","affiliation":[{"name":"Exeter NIHR Clinical Research Facility, Royal Devon and Exeter NHS Foundation Trust, Exeter, U.K."},{"name":"Institute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janine","family":"Sanchez","sequence":"additional","affiliation":[{"name":"Miller School of Medicine, University of Miami, Miami, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Piccini","sequence":"additional","affiliation":[{"name":"Regional Center for Pediatric Diabetes, Meyer University Children\u2019s Hospital, Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3759-3490","authenticated-orcid":false,"given":"Jacques","family":"Beltrand","sequence":"additional","affiliation":[{"name":"Service d\u2019Endocrinologie, Gyn\u00e9cologie et Diab\u00e9tologie P\u00e9daitrique, APHP Centre, Universit\u00e9 de Paris, Paris, France"},{"name":"INSERM U1016, Paris, France"},{"name":"Institut IMAGINE, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa R.","family":"Letourneau-Freiberg","sequence":"additional","affiliation":[{"name":"Kovler Diabetes Center, The University of Chicago, Chicago, IL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Polak","sequence":"additional","affiliation":[{"name":"Service d\u2019Endocrinologie, Gyn\u00e9cologie et Diab\u00e9tologie P\u00e9daitrique, APHP Centre, Universit\u00e9 de Paris, Paris, France"},{"name":"INSERM U1016, Paris, France"},{"name":"Institut IMAGINE, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siri Atma W.","family":"Greeley","sequence":"additional","affiliation":[{"name":"Kovler Diabetes Center, The University of Chicago, Chicago, IL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eamon","family":"Rawlins","sequence":"additional","affiliation":[{"name":"Institute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarig","family":"Babiker","sequence":"additional","affiliation":[{"name":"Institute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas J.","family":"Thomas","sequence":"additional","affiliation":[{"name":"Institute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1437-7891","authenticated-orcid":false,"given":"Elisa","family":"De Franco","sequence":"additional","affiliation":[{"name":"Institute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sian","family":"Ellard","sequence":"additional","affiliation":[{"name":"Institute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah E.","family":"Flanagan","sequence":"additional","affiliation":[{"name":"Institute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5620-473X","authenticated-orcid":false,"given":"Andrew T.","family":"Hattersley","sequence":"additional","affiliation":[{"name":"Exeter NIHR Clinical Research Facility, Royal Devon and Exeter NHS Foundation Trust, Exeter, U.K."},{"name":"Institute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Neonatal Diabetes International Collaborative Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fauzia","family":"Mohsin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Cummings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"LeGault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zubin","family":"Punthakee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Van Der Meulen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethel","family":"Codner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian","family":"Gallardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meena","family":"Rafiq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayne","family":"Houghton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kashyap","family":"Amratlal Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamsin","family":"Ford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janani","family":"Kumaraguru Pillai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roisin","family":"Finn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Chakera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klemens","family":"Raile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Schebek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Werner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vandana","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmeline","family":"Heffernan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brunella","family":"Iovane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bastiaan","family":"De Galan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Voorhoeve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pal","family":"Njolstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asta","family":"Sulen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Dankovcikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Gasperikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juraj","family":"Stanik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Banu","family":"Aydin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Firdevs","family":"Bas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruveyde","family":"Bundak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feyza","family":"Darendeliler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanca","family":"Raceala-Motoc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan C.","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine E.","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kara W.","family":"Greeley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2020,11,12]]},"reference":[{"key":"2022031222432173100_B1","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1126\/science.7716547","article-title":"Cloning of the beta cell high-affinity sulfonylurea receptor: a regulator of insulin secretion","volume":"268","author":"Aguilar-Bryan","year":"1995","journal-title":"Science"},{"key":"2022031222432173100_B2","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0896-6273(00)80321-9","article-title":"Association and stoichiometry of K(ATP) channel subunits","volume":"18","author":"Clement","year":"1997","journal-title":"Neuron"},{"key":"2022031222432173100_B3","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0140-6736(15)60098-8","article-title":"The effect of early, comprehensive genomic testing on clinical care in neonatal diabetes: an international cohort study","volume":"386","author":"De Franco","year":"2015","journal-title":"Lancet"},{"key":"2022031222432173100_B4","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.2337\/db07-0043","article-title":"Mutations in ATP-sensitive K+ channel genes cause transient neonatal diabetes and permanent diabetes in childhood or adulthood","volume":"56","author":"Flanagan","year":"2007","journal-title":"Diabetes"},{"key":"2022031222432173100_B5","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S2213-8587(13)70059-7","article-title":"Neuropsychological dysfunction and developmental defects associated with genetic changes in infants with neonatal diabetes mellitus: a prospective cohort study [corrected]","volume":"1","author":"Busiah","year":"2013","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2022031222432173100_B6","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1056\/NEJMoa055068","article-title":"Activating mutations in the ABCC8 gene in neonatal diabetes mellitus","volume":"355","author":"Babenko","year":"2006","journal-title":"N Engl J Med"},{"key":"2022031222432173100_B7","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1056\/NEJMoa032922","article-title":"Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes","volume":"350","author":"Gloyn","year":"2004","journal-title":"N Engl J Med"},{"key":"2022031222432173100_B8","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1056\/NEJMoa061759","article-title":"Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations","volume":"355","author":"Pearson","year":"2006","journal-title":"N Engl J Med"},{"key":"2022031222432173100_B9","doi-asserted-by":"crossref","first-page":"204","DOI":"10.2337\/dc07-1785","article-title":"Effective treatment with oral sulfonylureas in patients with diabetes due to sulfonylurea receptor 1 (SUR1) mutations","volume":"31","author":"Rafiq","year":"2008","journal-title":"Diabetes Care"},{"key":"2022031222432173100_B10","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/edn.60","article-title":"Transforming lives: transferring patients with neonatal diabetes from insulin to sulphonylureas","volume":"3","author":"Shepherd","year":"2006","journal-title":"Eur Diabetes Nurs"},{"key":"2022031222432173100_B11","first-page":"637","article-title":"Effectiveness and safety of long-term treatment with sulfonylureas in patients with neonatal diabetes due to KCNJ11 mutations: an international cohort study","volume-title":"Lancet Diabetes Endocrinol","author":"Bowman","year":"2018"},{"key":"2022031222432173100_B12","doi-asserted-by":"crossref","first-page":"157","DOI":"10.4093\/dmj.2013.37.3.157","article-title":"Neonatal diabetes caused by activating mutations in the sulphonylurea receptor","volume":"37","author":"Proks","year":"2013","journal-title":"Diabetes Metab J"},{"key":"2022031222432173100_B13","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1172\/JCI25495","article-title":"ATP-sensitive potassium channelopathies: focus on insulin secretion","volume":"115","author":"Ashcroft","year":"2005","journal-title":"J Clin Invest"},{"key":"2022031222432173100_B14","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/0014-5793(95)01369-5","article-title":"Cloning and functional expression of the cDNA encoding a novel ATP-sensitive potassium channel subunit expressed in pancreatic beta-cells, brain, heart and skeletal muscle","volume":"377","author":"Sakura","year":"1995","journal-title":"FEBS Lett"},{"key":"2022031222432173100_B15","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/sj.ejhg.5201629","article-title":"KCNJ11 activating mutations are associated with developmental delay, epilepsy and neonatal diabetes syndrome and other neurological features","volume":"14","author":"Gloyn","year":"2006","journal-title":"Eur J Hum Genet"},{"key":"2022031222432173100_B16","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s11154-010-9149-x","article-title":"Permanent neonatal diabetes due to activating mutations in ABCC8 and KCNJ11","volume":"11","author":"Edghill","year":"2010","journal-title":"Rev Endocr Metab Disord"},{"key":"2022031222432173100_B17","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.2337\/dc15-0837","article-title":"Sulfonylurea therapy benefits neurological and psychomotor functions in patients with neonatal diabetes owing to potassium channel mutations","volume":"38","author":"Beltrand","year":"2015","journal-title":"Diabetes Care"},{"key":"2022031222432173100_B18","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/pedi.12447","article-title":"Molecular and clinical features of KATP -channel neonatal diabetes mellitus in Japan","volume":"18","author":"Hashimoto","year":"2017","journal-title":"Pediatr Diabetes"},{"key":"2022031222432173100_B19","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1098\/rstb.2008.0142","article-title":"Review. SUR1: a unique ATP-binding cassette protein that functions as an ion channel regulator","volume":"364","author":"Aittoniemi","year":"2009","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"2022031222432173100_B20","unstructured":"Joint Formulary Committee. British National Formulary. London, BMJ Group and Pharmaceutical Press. Accessed 1 April 2020. Available from https:\/\/www.medicinescomplete.com"},{"key":"2022031222432173100_B21","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.2337\/dc06-2134","article-title":"Sulfonylurea treatment in young children with neonatal diabetes: dealing with hyperglycemia, hypoglycemia, and sick days","volume":"30","author":"Codner","year":"2007","journal-title":"Diabetes Care"},{"key":"2022031222432173100_B22","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/pedi.12174","article-title":"ISPAD Clinical Practice Consensus Guidelines 2014. Assessment and management of hypoglycemia in children and adolescents with diabetes","volume":"15","author":"Ly","year":"2014","journal-title":"Pediatr Diabetes"},{"key":"2022031222432173100_B23","unstructured":"Diabetes Genes, Exeter. Sulphonylurea transfer in patients with KCNJ11 and ABCC8 mutations\u2014TNDM. Accessed 1 May 2020. Available at https:\/\/www.diabetesgenes.org\/about-neonatal-diabetes\/transferring-patients-who-have-a-mutation-in-kcnj11-or-abcc8"},{"key":"2022031222432173100_B24","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1111\/dme.13135","article-title":"Psychiatric morbidity in children with KCNJ11 neonatal diabetes","volume":"33","author":"Bowman","year":"2016","journal-title":"Diabet Med"},{"key":"2022031222432173100_B25","doi-asserted-by":"crossref","first-page":"526","DOI":"10.2337\/dc19-1013","article-title":"Intellectual disability in KATP channel neonatal diabetes","volume":"43","author":"Svalastoga","year":"2020","journal-title":"Diabetes Care"},{"key":"2022031222432173100_B26","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.2337\/dc11-2225","article-title":"Visuomotor performance in KCNJ11-related neonatal diabetes is impaired in children with DEND-associated mutations and may be improved by early treatment with sulfonylureas","volume":"35","author":"Shah","year":"2012","journal-title":"Diabetes Care"},{"key":"2022031222432173100_B27","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1540-5834.2011.00631.x","article-title":"Sensitive periods","volume":"76","author":"Zeanah","year":"2011","journal-title":"Monogr Soc Res Child Dev"},{"key":"2022031222432173100_B28","first-page":"e0134476","article-title":"Systemic administration of glibenclamide fails to achieve therapeutic levels in the brain and cerebrospinal fluid of rodents","volume-title":"PLoS One","author":"Lahmann","year":"2015"},{"key":"2022031222432173100_B29","unstructured":"Diabetes Genes, Exeter. Effects of sulphonylurea on the brain. Accessed 1 May 2020. Available at https:\/\/www.diabetesgenes.org\/about-neonatal-diabetes\/effects-of-sulphonylurea-on-the-brain"},{"key":"2022031222432173100_B30","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1086\/519174","article-title":"Permanent neonatal diabetes caused by dominant, recessive, or compound heterozygous SUR1 mutations with opposite functional effects","volume":"81","author":"Ellard","year":"2007","journal-title":"Am J Hum Genet"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/care.diabetesjournals.org\/syndication\/doi\/10.2337\/dc20-1520","content-type":"unspecified","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/44\/1\/35\/532389\/dc201520.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/44\/1\/35\/532389\/dc201520.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,13]],"date-time":"2022-03-13T00:59:38Z","timestamp":1647133178000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/44\/1\/35\/33255\/Long-term-Follow-up-of-Glycemic-and-Neurological"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,12]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,11,12]]},"published-print":{"date-parts":[[2021,1,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dc20-1520","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,12]]}}}